# Effect of Ketamine on Fatigue Following Cancer Therapy

> **NCT02317341** · EARLY_PHASE1 · TERMINATED · sponsor: **National Institute of Nursing Research (NINR)** · enrollment: 2 (actual)

## Conditions studied

- Cancer
- Fatigue
- Ketamine

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Placebo (saline)
- **DRUG:** Ketamine
- **DRUG:** Midazolam
- **DRUG:** Midazolam(placebo)

## Key facts

- **NCT ID:** NCT02317341
- **Lead sponsor:** National Institute of Nursing Research (NINR)
- **Sponsor class:** NIH
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-12-13
- **Primary completion:** 2019-03-18
- **Final completion:** 2019-03-18
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2019-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02317341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02317341, "Effect of Ketamine on Fatigue Following Cancer Therapy". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02317341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*